Kancera AB (publ) - Asset Resilience Ratio

Latest as of March 2025: 65.98%

Kancera AB (publ) (KAN) has an Asset Resilience Ratio of 65.98% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr37.34 Million

≈ $4.02 Million USD Cash + Short-term Investments

Total Assets

Skr56.60 Million

≈ $6.09 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Kancera AB (publ)'s Asset Resilience Ratio has changed over time. Check KAN strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Kancera AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Kancera AB (publ) (KAN) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr37.34 Million	65.98%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr37.34 Million	65.98%

Asset Resilience Insights

Very High Liquidity: Kancera AB (publ) maintains exceptional liquid asset reserves at 65.98% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Kancera AB (publ) Industry Peers by Asset Resilience Ratio

Compare Kancera AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Kancera AB (publ) (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Kancera AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	69.29%	Skr46.36 Million ≈ $4.99 Million	Skr66.91 Million ≈ $7.20 Million	-0.32pp
2023-12-31	69.61%	Skr45.69 Million ≈ $4.92 Million	Skr65.64 Million ≈ $7.06 Million	-9.20pp
2022-12-31	78.81%	Skr95.15 Million ≈ $10.24 Million	Skr120.74 Million ≈ $12.99 Million	-1.04pp
2021-12-31	79.85%	Skr106.52 Million ≈ $11.46 Million	Skr133.41 Million ≈ $14.36 Million	+13.65pp
2020-12-31	66.19%	Skr55.01 Million ≈ $5.92 Million	Skr83.10 Million ≈ $8.94 Million	+39.48pp
2019-12-31	26.71%	Skr11.85 Million ≈ $1.28 Million	Skr44.35 Million ≈ $4.77 Million	-19.46pp
2018-12-31	46.17%	Skr21.02 Million ≈ $2.26 Million	Skr45.53 Million ≈ $4.90 Million	-8.05pp
2017-12-31	54.22%	Skr27.77 Million ≈ $2.99 Million	Skr51.23 Million ≈ $5.51 Million	-24.87pp
2016-12-31	79.09%	Skr57.76 Million ≈ $6.22 Million	Skr73.03 Million ≈ $7.86 Million	+78.92pp
2011-12-31	0.17%	Skr67.00K ≈ $7.21K	Skr39.74 Million ≈ $4.28 Million	--

pp = percentage points

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#29994 Global

#689 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr1.42

All Time High

Skr38.15